Regulation of B cell receptor signalling by Epstein-Barr virus nuclear antigens
Open Access
- 30 November 2022
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 479 (23), 2395-2417
- https://doi.org/10.1042/BCJ20220417
Abstract
The cancer-associated Epstein-Barr virus (EBV) latently infects and immortalises B lymphocytes. EBV latent membrane protein 2A and EBV-encoded microRNAs are known to manipulate B cell receptor signalling to control cell growth and survival and suppress lytic replication. Here, we show that the EBV transcription factors EBNA2, 3A, 3B and 3C bind to genomic sites around multiple B cell receptor (BCR) pathway genes, regulate their expression and affect BCR signalling. EBNA2 regulates the majority of BCR pathway genes associated with binding sites, where EBNA3 proteins regulate only 42% of targets predicted by binding. Both EBNA2 and 3 proteins predominantly repress BCR pathway gene expression and target some common genes. EBNA2 and at least one EBNA3 protein repress the central BCR components CD79A and CD79B and the downstream genes BLNK, CD22, CD72, NFATC1, PIK3CG and RASGRP3. Studying repression of CD79B, we show that EBNA2 decreases transcription by disrupting binding of Early B cell Factor-1 to the CD79B promoter. Consistent with repression of BCR signalling, we demonstrate that EBNA2 and EBNA3 proteins suppress the basal or active BCR signalling that culminates in NFAT activation. Additionally, we show that EBNA2, EBNA3A and EBNA3C expression can result in reductions in the active serine 473 phosphorylated form of Akt in certain cell contexts, consistent with transcriptional repression of the PI3K-Akt BCR signalling arm. Overall, we identify EBNA2, EBNA3A and EBNA3C-mediated transcription control of BCR signalling as an additional strategy through which EBV may control the growth and survival of infected B cells and maintain viral latency.This publication has 74 references indexed in Scilit:
- Modulation of Enhancer Looping and Differential Gene Targeting by Epstein-Barr Virus Transcription Factors Directs Cellular ReprogrammingPLoS Pathogens, 2013
- Downregulation of Integrin Receptor-Signaling Genes by Epstein-Barr Virus EBNA 3C via Promoter-Proximal and -Distal Binding ElementsJournal of Virology, 2012
- Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growthProceedings of the National Academy of Sciences of the United States of America, 2011
- Epstein–Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell linesProceedings of the National Academy of Sciences of the United States of America, 2010
- Extensive Co-Operation between the Epstein-Barr Virus EBNA3 Proteins in the Manipulation of Host Gene Expression and Epigenetic Chromatin ModificationPLOS ONE, 2010
- Epigenetic Repression of p16INK4A by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBPPLoS Pathogens, 2010
- Differential Gene Regulation by Epstein-Barr Virus Type 1 and Type 2 EBNA2Journal of Virology, 2008
- EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathwayJournal of General Virology, 2008
- Cellular Target Genes of Epstein-Barr Virus Nuclear Antigen 2Journal of Virology, 2006
- Epstein-Barr Virus LMP2A Enhances B-Cell Responses In Vivo and In VitroJournal of Virology, 2006